Table 4.

Incidence rate of glioma patients among countries.

Year of publication	Statistical years	Country	Data source	Incidence rate (per 100,000)	Tumor type	Authors
2021	2007-2017	Korea	Korean National Health Insurance Database (NHID)	7.47	glioma	Kim et al. (11)
2020	1995	England	Canadian Cancer Registry and Central Brain Tumor Registry of the United States (CBTRUS)	2.39	glioblastoma	Davis et al. (12)
2020	1995	Canada		3.56
2020	1995	USA		3.92
2020	2015	England		5.02
2020	2015	Canada		4.50
2020	2015	USA		4.32
2019	2011-2015	USA-high SES	Central Brain Tumor Registry of the United States (CBTRUS)	5.88	glioma	Cote et al. (13)
2019	2011-2015	USA-low SES		5.52	glioma
2019	2011-2015	USA-high SES		3.16	glioblastoma
2019	2011-2015	USA-low SES		2.95	glioblastoma
2019	1990-2006	Finland	Finnish Cancer Registry (FCR)	7.70	glioma	Natukka et al. (14)
2019	2007-2016			7.30
2018	1973-2014	USA	SEER	6.90	glioma	Li et al. (15)
2018	1973-2014			4.10	glioblastoma
2017	2009-2014	Denmark	Danish Neuro-Oncology Registry (DNOR)	7.30	glioma	Rasmussen et al. (16)
2017	2009-2014			5.10	glioblastoma
2017	2013	Korea	Korean Central Cancer Registry	2.82	glioblastoma	Dho et al. (17)
2016	2001-2007	England-white	National Cancer Intelligence Network	4.80	glioma	Maile et al. (18)
2016	2005-2009	Canton of Zurich in Switzerland	Zurich and Zug Cancer Registry	3.90	glioblastoma	Gramatzki et al. (19)

SEER, Surveillance, Epidemiology, and End Results; SES, socioeconomic status.